Jeong Hun Kim Selected Research

Retinal Neovascularization

1/2018	Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.
8/2017	Intraocular application of gold nanodisks optically tuned for optical coherence tomography: inhibitory effect on retinal neovascularization without unbearable toxicity.
1/2017	Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
2/2015	Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
10/2014	Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors.
7/2014	Anti-angiogenic effect of bare titanium dioxide nanoparticles on pathologic neovascularization without unbearable toxicity.
5/2014	Beta-lapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1α.
3/2014	VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
11/2012	Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
7/2012	Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeong Hun Kim Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 09/2007
30	Retinoblastoma (Glioblastoma, Retinal) 10/2021 - 06/2003
18	Retinal Neovascularization 01/2018 - 11/2007
15	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2021 - 02/2008
13	Choroidal Neovascularization 01/2021 - 02/2008
12	Hypoxia (Hypoxemia) 01/2019 - 04/2007
10	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021 - 02/2008
10	Pathologic Neovascularization 10/2018 - 10/2008
9	Macular Degeneration (Age-Related Maculopathy) 07/2018 - 06/2007
8	Blindness (Hysterical Blindness) 10/2018 - 10/2010
7	Retinal Diseases 02/2021 - 07/2012
7	Retinal Detachment (Retinal Detachments) 12/2018 - 03/2010
6	Inflammation (Inflammations) 01/2021 - 02/2005
6	Cataract (Cataracts) 01/2019 - 12/2007
5	Ischemia 01/2019 - 07/2007
5	Ganglion Cysts (Ganglion) 08/2018 - 09/2007
4	Macular Edema 07/2020 - 10/2014
4	Alzheimer Disease (Alzheimer's Disease) 06/2017 - 01/2013
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 01/2017
3	Hyperglycemia 12/2020 - 09/2014
3	Hemorrhage 12/2018 - 06/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 12/2016
3	Atrophy 02/2016 - 01/2013
3	Uveitis 02/2014 - 07/2010
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 09/2021 - 01/2020
2	Keratitis 01/2021 - 10/2018
2	Dyslipidemias (Dyslipidemia) 07/2020 - 01/2017
2	Cysts 08/2018 - 01/2011
2	Corneal Neovascularization 01/2018 - 07/2015
2	Neoplasm Metastasis (Metastasis) 02/2017 - 03/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 06/2015
2	Retinal Degeneration 07/2015 - 01/2011
2	Vitreous Hemorrhage 06/2012 - 07/2010
2	Wounds and Injuries (Trauma) 06/2004 - 06/2003
1	Body Weight (Weight, Body) 04/2022
1	Starvation 02/2022
1	Lacrimal Duct Obstruction 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022

Drug/Important Bio-Agent (IBA)

36	Retinaldehyde (Retinal)IBA 01/2021 - 06/2003
28	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 02/2005
9	Oxygen (Dioxygen)IBA 01/2021 - 10/2008
7	Pharmaceutical PreparationsIBA 10/2021 - 03/2014
7	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 04/2009
7	Bevacizumab (Avastin)FDA Link 01/2020 - 11/2008
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2007
5	Biological ProductsIBA 01/2020 - 09/2007
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2021 - 09/2009
4	Small Interfering RNA (siRNA)IBA 12/2020 - 11/2014
4	Retinal Pigments (Pigments, Visual)IBA 01/2020 - 01/2010
4	GoldIBA 08/2017 - 12/2009
4	Amyloid beta-PeptidesIBA 06/2017 - 01/2013
3	Therapeutic UsesIBA 02/2021 - 10/2015
3	NF-kappa B (NF-kB)IBA 01/2021 - 02/2005
3	Amyloid (Amyloid Fibrils)IBA 11/2020 - 01/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 04/2009
3	deguelinIBA 11/2015 - 02/2008
3	Tight Junction ProteinsIBA 01/2014 - 04/2007
3	ClusterinIBA 12/2013 - 07/2007
3	Glial Fibrillary Acidic ProteinIBA 09/2010 - 09/2007
2	oligonolIBA 04/2022 - 09/2021
2	CalciumIBA 10/2021 - 10/2008
2	arginyl-leucyl-tyrosyl-glutamic acidIBA 02/2021 - 01/2019
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 10/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 07/2020 - 01/2017
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2014
2	RibonucleoproteinsIBA 07/2018 - 01/2017
2	RNA (Ribonucleic Acid)IBA 07/2018 - 01/2017
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2018 - 08/2010
2	Carboplatin (JM8)FDA LinkGeneric 02/2017 - 07/2013
2	LDL CholesterolIBA 01/2017 - 04/2012
2	LipidsIBA 01/2017 - 04/2012
2	HDL CholesterolIBA 01/2017 - 04/2012
2	MicroRNAs (MicroRNA)IBA 11/2014 - 10/2011
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2014 - 06/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2013 - 03/2010
2	Thromboplastin (Tissue Factor)IBA 12/2012 - 09/2011
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 12/2012 - 09/2011
2	Hypoxia-Inducible Factor 1IBA 11/2012 - 03/2010
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2012 - 01/2009
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2011 - 03/2010
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 02/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2021 - 12/2007
11	Lasers (Laser) 01/2021 - 03/2009
10	Drug Therapy (Chemotherapy) 01/2021 - 06/2003
7	Intravitreal Injections 01/2019 - 09/2009
6	Transplantation 01/2021 - 09/2011
6	Vitrectomy 08/2012 - 06/2009
5	Intraocular Lenses (Intraocular Lens) 01/2019 - 12/2007
3	Immunotherapy 01/2022 - 01/2021
3	Radiotherapy 04/2019 - 10/2014
3	Intraocular Lens Implantation 02/2017 - 12/2007
3	Cataract Extraction 02/2017 - 06/2012
2	Proton Therapy 11/2018 - 12/2011
2	Intravenous Administration 01/2018 - 11/2008
2	Light Coagulation 04/2013 - 08/2010
2	Telescopes 05/2012 - 12/2007